Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT04047628 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

156

Enrollment

NIH

Sponsor class

Conditions

Relapsing Multiple Sclerosis
Relapsing Remitting Multiple Sclerosis
Secondary Progressive Multiple Sclerosis

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Best Available Therapy (BAT)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]